Norway, April 21 -- Gentian Diagnostics, a fast-growing developer and manufacturer of high-quality diagnostic assays, is pleased to announce the renewal of its long-term supply agreement with Buhlmann Laboratories for faecal calprotectin. Under the renewed agreement, Gentian will continue to supply key materials for Buhlmann Laboratories market-leading faecal calprotectin assay, fCAL Turbo(R). The renewal underscores the strength of the long standing collaboration between Gentian and Buhlmann Laboratories and reflects a shared commitment to advancing faecal calprotectin testing to support improved diagnosis and monitoring of inflammatory bowel disease.
Published by HT Digital Content Services with permission from Pivotal Sources....